复发风险-话题@MedSci

#复发风险#

194篇内容 | 3585人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1905574, encodeId=301519055e469, content=<a href='/topic/show?id=0eb34259ea1' target=_blank style='color:#2F92EE;'>#复发风险#</a>, objectTitle=Ther Adv Med Oncol：激素受体状态会影响高BMI和高血糖对早期HER2+乳腺癌患者肿瘤复发风险的影响, objectType=article, longId=210916, objectId=b038210916f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b038210916f9, replyNumber=0, likeNumber=83, createdTime=2021-07-19, rootId=0, userName=wushaoling, userId=ca20190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b038210916f9, moduleTitle=Ther Adv Med Oncol：激素受体状态会影响高BMI和高血糖对早期HER2+乳腺癌患者肿瘤复发风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b038210916f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905575, encodeId=5dfa19055e5b7, content=<a href='/topic/show?id=0eb34259ea1' target=_blank style='color:#2F92EE;'>#复发风险#</a>, objectTitle=JAMA：传统合成改善病情抗风湿药维持治疗药物剂量对复发风险的影响, objectType=article, longId=210945, objectId=ba132109453b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba132109453b, replyNumber=0, likeNumber=80, createdTime=2022-02-05, rootId=0, userName=wushaoling, userId=ca20190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba132109453b, moduleTitle=JAMA：传统合成改善病情抗风湿药维持治疗药物剂量对复发风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba132109453b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905576, encodeId=059c19055e66a, content=<a href='/topic/show?id=0eb34259ea1' target=_blank style='color:#2F92EE;'>#复发风险#</a>, objectTitle=PLoS Medicine:ctDNA预测大肠癌肝转移患者复发风险, objectType=article, longId=211458, objectId=2c0f21145889, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c0f21145889, replyNumber=0, likeNumber=69, createdTime=2022-04-20, rootId=0, userName=wushaoling, userId=ca20190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c0f21145889, moduleTitle=PLoS Medicine:ctDNA预测大肠癌肝转移患者复发风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c0f21145889)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905563, encodeId=e2df190556399, content=<a href='/topic/show?id=0eb34259ea1' target=_blank style='color:#2F92EE;'>#复发风险#</a>, objectTitle=J Clin Oncol：III期SORCE | 索拉非尼不能用作中高复发风险的原发肾癌的术后辅助治疗, objectType=article, longId=202290, objectId=28a7202290f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28a7202290f1, replyNumber=0, likeNumber=51, createdTime=2021-02-25, rootId=0, userName=wushaoling, userId=ca20190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28a7202290f1, moduleTitle=J Clin Oncol：III期SORCE | 索拉非尼不能用作中高复发风险的原发肾癌的术后辅助治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28a7202290f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905559, encodeId=320d190555903, content=<a href='/topic/show?id=0eb34259ea1' target=_blank style='color:#2F92EE;'>#复发风险#</a>, objectTitle=NEJM重磅：提前2年揭盲！吴一龙联合全球和国内284个中心团队，发现手术+精准分型靶向治疗降低早中期肺癌术后83%复发风险, objectType=article, longId=201102, objectId=815b20110216, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=815b20110216, replyNumber=0, likeNumber=74, createdTime=2021-01-30, rootId=0, userName=wushaoling, userId=ca20190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=815b20110216, moduleTitle=NEJM重磅：提前2年揭盲！吴一龙联合全球和国内284个中心团队，发现手术+精准分型靶向治疗降低早中期肺癌术后83%复发风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=815b20110216)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905560, encodeId=3968190556071, content=<a href='/topic/show?id=0eb34259ea1' target=_blank style='color:#2F92EE;'>#复发风险#</a>, objectTitle=泰瑞沙在早期EGFR突变肺癌辅助治疗中可降低82%脑部复发风险, objectType=article, longId=201192, objectId=608e2011928b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=608e2011928b, replyNumber=0, likeNumber=0, createdTime=2021-06-22, rootId=0, userName=wushaoling, userId=ca20190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=608e2011928b, moduleTitle=泰瑞沙在早期EGFR突变肺癌辅助治疗中可降低82%脑部复发风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=608e2011928b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905571, encodeId=655b19055e172, content=<a href='/topic/show?id=0eb34259ea1' target=_blank style='color:#2F92EE;'>#复发风险#</a>, objectTitle=JCC：饮食摄入模式与IBD患者发生疾病复发风险有关, objectType=article, longId=206542, objectId=33da2065427c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33da2065427c, replyNumber=0, likeNumber=91, createdTime=2021-11-22, rootId=0, userName=wushaoling, userId=ca20190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33da2065427c, moduleTitle=JCC：饮食摄入模式与IBD患者发生疾病复发风险有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33da2065427c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905565, encodeId=5a85190556506, content=<a href='/topic/show?id=0eb34259ea1' target=_blank style='color:#2F92EE;'>#复发风险#</a>, objectTitle=JCO：为什么乳腺癌的四种复发风险预测分析结果不一样？, objectType=article, longId=203321, objectId=891820332169, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=891820332169, replyNumber=0, likeNumber=93, createdTime=2021-02-20, rootId=0, userName=wushaoling, userId=ca20190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=891820332169, moduleTitle=JCO：为什么乳腺癌的四种复发风险预测分析结果不一样？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=891820332169)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905555, encodeId=86e3190555522, content=<a href='/topic/show?id=0eb34259ea1' target=_blank style='color:#2F92EE;'>#复发风险#</a>, objectTitle=JACC:有脂肪肝的房颤患者，消融后房颤复发风险高！, objectType=article, longId=199509, objectId=ff0819950947, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff0819950947, replyNumber=0, likeNumber=84, createdTime=2021-01-29, rootId=0, userName=wushaoling, userId=ca20190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff0819950947, moduleTitle=JACC:有脂肪肝的房颤患者，消融后房颤复发风险高！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff0819950947)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905562, encodeId=6033190556285, content=<a href='/topic/show?id=0eb34259ea1' target=_blank style='color:#2F92EE;'>#复发风险#</a>, objectTitle=Clin Gastroenterology H: 患过恶性肿瘤的患者接受生物制剂治疗并不会增加肿瘤复发风险, objectType=article, longId=202136, objectId=0370202136f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0370202136f7, replyNumber=0, likeNumber=0, createdTime=2021-09-05, rootId=0, userName=wushaoling, userId=ca20190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0370202136f7, moduleTitle=Clin Gastroenterology H: 患过恶性肿瘤的患者接受生物制剂治疗并不会增加肿瘤复发风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0370202136f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905557, encodeId=5bd5190555e9e, content=<a href='/topic/show?id=0eb34259ea1' target=_blank style='color:#2F92EE;'>#复发风险#</a>, objectTitle=Blood：Getuzumab ozogamicin治疗对NPM1突变AML患者MRD和复发风险的影响, objectType=article, longId=200012, objectId=052a20001262, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=052a20001262, replyNumber=0, likeNumber=75, createdTime=2020-09-21, rootId=0, userName=wushaoling, userId=ca20190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=052a20001262, moduleTitle=Blood：Getuzumab ozogamicin治疗对NPM1突变AML患者MRD和复发风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=052a20001262)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905554, encodeId=9fb41905554fd, content=<a href='/topic/show?id=0eb34259ea1' target=_blank style='color:#2F92EE;'>#复发风险#</a>, objectTitle=JAMA Oncol：ctDNA和循环肿瘤细胞预测三阴性乳腺癌的复发风险, objectType=article, longId=197587, objectId=583719e5871f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=583719e5871f, replyNumber=0, likeNumber=69, createdTime=2020-10-05, rootId=0, userName=wushaoling, userId=ca20190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=583719e5871f, moduleTitle=JAMA Oncol：ctDNA和循环肿瘤细胞预测三阴性乳腺癌的复发风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=583719e5871f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905558, encodeId=1bd81905558a7, content=<a href='/topic/show?id=0eb34259ea1' target=_blank style='color:#2F92EE;'>#复发风险#</a>, objectTitle=闪耀ESMO！礼来阿贝西利(abemaciclib)显著降低HR+，HER2-高危早期乳腺癌患者复发风险达25%, objectType=article, longId=201086, objectId=83de20108654, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83de20108654, replyNumber=0, likeNumber=71, createdTime=2021-04-13, rootId=0, userName=wushaoling, userId=ca20190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83de20108654, moduleTitle=闪耀ESMO！礼来阿贝西利(abemaciclib)显著降低HR+，HER2-高危早期乳腺癌患者复发风险达25%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83de20108654)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905570, encodeId=a3cd19055e028, content=<a href='/topic/show?id=0eb34259ea1' target=_blank style='color:#2F92EE;'>#复发风险#</a>, objectTitle=J Clin Oncol：基于分子和临床病理特征的临床计算器可预测I-III期结肠癌术后的复发风险, objectType=article, longId=206356, objectId=669420635671, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=669420635671, replyNumber=0, likeNumber=66, createdTime=2021-06-26, rootId=0, userName=wushaoling, userId=ca20190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=669420635671, moduleTitle=J Clin Oncol：基于分子和临床病理特征的临床计算器可预测I-III期结肠癌术后的复发风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=669420635671)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905566, encodeId=df7b1905566d6, content=<a href='/topic/show?id=0eb34259ea1' target=_blank style='color:#2F92EE;'>#复发风险#</a>, objectTitle=Blood：ALL儿童患者停用天冬酰胺酶后的复发风险, objectType=article, longId=203509, objectId=aef020350972, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aef020350972, replyNumber=0, likeNumber=68, createdTime=2021-10-12, rootId=0, userName=wushaoling, userId=ca20190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aef020350972, moduleTitle=Blood：ALL儿童患者停用天冬酰胺酶后的复发风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aef020350972)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905572, encodeId=a95c19055e2d9, content=<a href='/topic/show?id=0eb34259ea1' target=_blank style='color:#2F92EE;'>#复发风险#</a>, objectTitle=纳武利尤单抗用于根治手术后高复发风险肌层浸润性尿路上皮癌治疗取得成功（CheckMate -274研究）, objectType=article, longId=207160, objectId=c47f20e16003, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c47f20e16003, replyNumber=0, likeNumber=99, createdTime=2021-04-04, rootId=0, userName=wushaoling, userId=ca20190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c47f20e16003, moduleTitle=纳武利尤单抗用于根治手术后高复发风险肌层浸润性尿路上皮癌治疗取得成功（CheckMate -274研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c47f20e16003)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905553, encodeId=d6531905553f1, content=<a href='/topic/show?id=0eb34259ea1' target=_blank style='color:#2F92EE;'>#复发风险#</a>, objectTitle=Blood：DHFR和FPGS胚系突变对甲氨蝶呤代谢和ALL复发风险的影响, objectType=article, longId=195453, objectId=fe4b1954530b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe4b1954530b, replyNumber=0, likeNumber=68, createdTime=2020-08-22, rootId=0, userName=wushaoling, userId=ca20190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe4b1954530b, moduleTitle=Blood：DHFR和FPGS胚系突变对甲氨蝶呤代谢和ALL复发风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe4b1954530b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905564, encodeId=9edb190556474, content=<a href='/topic/show?id=0eb34259ea1' target=_blank style='color:#2F92EE;'>#复发风险#</a>, objectTitle=NEJM：提前2年揭盲！吴一龙联合全球和国内284个中心团队，发现手术+精准分型靶向治疗降低早中期肺癌术后83%复发风险, objectType=article, longId=202657, objectId=911020265e37, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=911020265e37, replyNumber=0, likeNumber=129, createdTime=2021-05-31, rootId=0, userName=wushaoling, userId=ca20190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=911020265e37, moduleTitle=NEJM：提前2年揭盲！吴一龙联合全球和国内284个中心团队，发现手术+精准分型靶向治疗降低早中期肺癌术后83%复发风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=911020265e37)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905568, encodeId=dcf51905568a1, content=<a href='/topic/show?id=0eb34259ea1' target=_blank style='color:#2F92EE;'>#复发风险#</a>, objectTitle= Blood：吉妥单抗可有效降低NPM1突变型AML患者的复发风险(AMLSG09-09试验), objectType=article, longId=205051, objectId=658520505129, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=658520505129, replyNumber=0, likeNumber=68, createdTime=2021-05-29, rootId=0, userName=wushaoling, userId=ca20190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=658520505129, moduleTitle= Blood：吉妥单抗可有效降低NPM1突变型AML患者的复发风险(AMLSG09-09试验), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=658520505129)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905548, encodeId=3ca01905548d2, content=<a href='/topic/show?id=0eb34259ea1' target=_blank style='color:#2F92EE;'>#复发风险#</a>, objectTitle=AP&T：完全的组织学正常化与内镜缓解的溃疡性结肠炎患者复发风险降低相关, objectType=article, longId=188218, objectId=410c188218d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=410c188218d2, replyNumber=0, likeNumber=59, createdTime=2020-04-24, rootId=0, userName=wushaoling, userId=ca20190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=410c188218d2, moduleTitle=AP&T：完全的组织学正常化与内镜缓解的溃疡性结肠炎患者复发风险降低相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=410c188218d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

复发风险

2020-05-29

wushaoling (审核中...)

前往app查看评论内容

#复发风险#

Ther Adv Med Oncol：激素受体状态会影响高BMI和高血糖对早期HER2+乳腺癌患者肿瘤复发风险的影响

2021-07-19

wushaoling (审核中...)

前往app查看评论内容

#复发风险#

JAMA：传统合成改善病情抗风湿药维持治疗药物剂量对复发风险的影响

2022-02-05

wushaoling (审核中...)

前往app查看评论内容

#复发风险#

PLoS Medicine:ctDNA预测大肠癌肝转移患者复发风险

2022-04-20

wushaoling (审核中...)

前往app查看评论内容

#复发风险#

J Clin Oncol：III期SORCE | 索拉非尼不能用作中高复发风险的原发肾癌的术后辅助治疗

2021-02-25

wushaoling (审核中...)

前往app查看评论内容

#复发风险#

NEJM重磅：提前2年揭盲！吴一龙联合全球和国内284个中心团队，发现手术+精准分型靶向治疗降低早中期肺癌术后83%复发风险

2021-01-30

wushaoling (审核中...)

前往app查看评论内容

#复发风险#

泰瑞沙在早期EGFR突变肺癌辅助治疗中可降低82%脑部复发风险

2021-06-22

wushaoling (审核中...)

前往app查看评论内容

#复发风险#

JCC：饮食摄入模式与IBD患者发生疾病复发风险有关

2021-11-22

wushaoling (审核中...)

前往app查看评论内容

#复发风险#

JCO：为什么乳腺癌的四种复发风险预测分析结果不一样？

2021-02-20

wushaoling (审核中...)

前往app查看评论内容

#复发风险#

JACC:有脂肪肝的房颤患者，消融后房颤复发风险高！

2021-01-29

wushaoling (审核中...)

前往app查看评论内容

#复发风险#

Clin Gastroenterology H: 患过恶性肿瘤的患者接受生物制剂治疗并不会增加肿瘤复发风险

2021-09-05

wushaoling (审核中...)

前往app查看评论内容

#复发风险#

Blood：Getuzumab ozogamicin治疗对NPM1突变AML患者MRD和复发风险的影响

2020-09-21

wushaoling (审核中...)

前往app查看评论内容

#复发风险#

JAMA Oncol：ctDNA和循环肿瘤细胞预测三阴性乳腺癌的复发风险

2020-10-05

wushaoling (审核中...)

前往app查看评论内容

#复发风险#

闪耀ESMO！礼来阿贝西利(abemaciclib)显著降低HR+，HER2-高危早期乳腺癌患者复发风险达25%

2021-04-13

wushaoling (审核中...)

前往app查看评论内容

#复发风险#

J Clin Oncol：基于分子和临床病理特征的临床计算器可预测I-III期结肠癌术后的复发风险

2021-06-26

wushaoling (审核中...)

前往app查看评论内容

#复发风险#

Blood：ALL儿童患者停用天冬酰胺酶后的复发风险

2021-10-12

wushaoling (审核中...)

前往app查看评论内容

#复发风险#

纳武利尤单抗用于根治手术后高复发风险肌层浸润性尿路上皮癌治疗取得成功（CheckMate -274研究）

2021-04-04

wushaoling (审核中...)

前往app查看评论内容

#复发风险#

Blood：DHFR和FPGS胚系突变对甲氨蝶呤代谢和ALL复发风险的影响

2020-08-22

wushaoling (审核中...)

前往app查看评论内容

#复发风险#

NEJM：提前2年揭盲！吴一龙联合全球和国内284个中心团队，发现手术+精准分型靶向治疗降低早中期肺癌术后83%复发风险

2021-05-31

wushaoling (审核中...)

前往app查看评论内容

#复发风险#

Blood：吉妥单抗可有效降低NPM1突变型AML患者的复发风险(AMLSG09-09试验)

2021-05-29

wushaoling (审核中...)

前往app查看评论内容

#复发风险#

AP&T：完全的组织学正常化与内镜缓解的溃疡性结肠炎患者复发风险降低相关

2020-04-24

科室
- - 订阅+
  - 更多科室
工具
服务